Cardio Vascular Dynamics' (CVD) controlled angioplasty technology (CAT) catheters approved in Japan:
This article was originally published in Clinica
Executive Summary
Cardio Vascular Dynamics' (US) controlled angioplasty technology (CAT) catheter has been approved for marketing in Japan. The company's Japanese distributor, Fukuda Denshi, will begin marketing the catheters in the final quarter this year. The devices use CVD's Focal expansion technology to perform percutaneous transluminal coronary angioplasty using both low and high balloon inflation pressures within a single catheter. Eight CAT models, including both over-the-wire and rail-design catheters, have been approved in total in Japan. CVD's European manufacturing plant will produce the catheters for the Japanese market.